Prescription drug · ANDA
gabapentin NDC 70771-1917
Gabapentin 750 mg/1 · Tablet · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1917-1 | 70771191701 | 100 TABLET in 1 BOTTLE (70771-1917-1)Marketed from Sep 18, 2025 | |
| 70771-1917-6 | 70771191706 | 60 TABLET in 1 BOTTLE (70771-1917-6)Marketed from Sep 18, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- gabapentin
- Generic name (nonproprietary)
- gabapentin
- Active ingredients
- Gabapentin — 750 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203934
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 70771-1917_ba40713a-2f22-4276-a664-355e7442cda4SPL ID ba40713a-2f22-4276-a664-355e7442cda4SPL set ID 8c0eeefc-ef5b-49f4-8411-ddbae312ed05RxCUI 1806380, 1806382, 2634743, 2634747, 2634751UNII 6CW7F3G59XUPC 0368382608161, 0368382607164
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771191701followed by a unit qualifier and the quantityPackage 70771-1917-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 203934
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| gabapentin | Gabapentin 900 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1918 |
| gabapentin | Gabapentin 900 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-357 |
| gabapentin | Gabapentin 450 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-355 |
| gabapentin | Gabapentin 750 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-356 |
| gabapentin | Gabapentin 450 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1916 |
| gabapentin | Gabapentin 600 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-607 |
| gabapentin | Gabapentin 300 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-608 |
| gabapentin | Gabapentin 600 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1862 |
| gabapentin | Gabapentin 300 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1861 |